 | | | | Debt-laden Italy finds itself in markets' crosshairs again, as the prospect of a collapse in its national unity government coincides with the European Central Bank preparing to deliver its first interest rate rise in 11 years. | | | | | | Abbott Laboratories on Wednesday raised its annual earnings forecast as demand for its medical devices and diagnostics products helped cushion the impact of a shutdown of its baby formula plant. | | | | | | Nasdaq Inc posted a 10% drop in second-quarter profit on Wednesday hit by expenses, even as revenue saw an uptick as traders turned to investment-related products to beat market volatility. | | | | | | The acting head of the Federal Aviation Administration (FAA) said on Wednesday that U.S. airlines' travel performance was improving after delays and cancellations have snarled traffic and prompted anger from lawmakers and passengers. | | | | | | Biogen Inc raised its annual adjusted profit forecast on Wednesday, as sales of blockbuster multiple sclerosis (MS) drug Tecfidera exceeded expectations despite increasing competition from generic drugs. | | | | | | Oilfield services provider Baker Hughes on Wednesday reported a bigger second-quarter loss, hit by a $365 million charge from suspension of its Russian operations and supply chain inflation, dampening the benefits of higher oil prices. | | | | | | Russia's central bank has proposed banning Russians with holdings worth less than $550,000 from buying foreign shares, as a step to protect investors after Western sanctions left them with billions of dollars in frozen accounts. | | | | | | Merck & Co Inc said on Wednesday its cancer therapy Keytruda failed to meet the main goal of a late-stage trial testing it in patients with head and neck cancer. | | | | | | China Evergrande New Energy Vehicle Group Ltd said on Wednesday it had received non-binding pre-orders for more than 37,000 units of its first model Hengchi 5. | | | | | | Elevance Health Inc lifted its annual earnings forecast on Wednesday after strength in the unit that houses its pharmacy benefits management business, IngenioRx, helped the company sail past market estimates for quarterly profit. | | | | | |
